201 related articles for article (PubMed ID: 1735693)
41. In vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.
Langenbacher M; Abdel-Jalil RJ; Voelter W; Weinmann M; Huber SM
Strahlenther Onkol; 2013 Mar; 189(3):246-54. PubMed ID: 23361139
[TBL] [Abstract][Full Text] [Related]
42. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
43. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
[TBL] [Abstract][Full Text] [Related]
44. Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.
Adams GE; Flockhart IR; Smithen CE; Stratford IJ; Wardman P; Watts ME
Radiat Res; 2012 Aug; 178(2):AV183-9. PubMed ID: 22870968
[No Abstract] [Full Text] [Related]
45. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 1996; 8(10-11):425-34. PubMed ID: 9114435
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
[TBL] [Abstract][Full Text] [Related]
47. Nitroimidazole radiopharmaceuticals in hypoxia: part II cytotoxicity and radiosensitization applications.
Sharma R
Curr Radiopharm; 2011 Oct; 4(4):379-93. PubMed ID: 22202160
[TBL] [Abstract][Full Text] [Related]
48. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
49. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues.
Watts ME; Jones NR
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):645-53. PubMed ID: 3873434
[TBL] [Abstract][Full Text] [Related]
50. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
51. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
Michaels HB
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
[TBL] [Abstract][Full Text] [Related]
52. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.
Skov KA; Farrell NP; Adomat H
Radiat Res; 1987 Nov; 112(2):273-82. PubMed ID: 3685256
[TBL] [Abstract][Full Text] [Related]
53. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
[TBL] [Abstract][Full Text] [Related]
54. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
55. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
DeGraff WG; Russo A; Gamson J; Mitchell JB
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
[TBL] [Abstract][Full Text] [Related]
57. Concepts and developments in radiosensitization of mammalian cells.
Stratford IJ
Int J Radiat Oncol Biol Phys; 1992; 22(3):529-32. PubMed ID: 1735691
[No Abstract] [Full Text] [Related]
58. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
Sakaguchi M; Webb MW; Agrawal KC
J Med Chem; 1982 Nov; 25(11):1339-42. PubMed ID: 6890579
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole.
Brezden CB; McClelland RA; Rauth AM
Biochem Pharmacol; 1994 Jul; 48(2):361-70. PubMed ID: 8053932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
